Related Experiment Video
Updated: May 3, 2026
Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in
Ruopeng Zha1, Weijie Guo1, Zhenfeng Zhang2
1Shanghai Medical College, Fudan University, Shanghai, China ; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Abstract:
MicroRNAs (miRNAs) are small, single-stranded, non-coding RNAs that play pivotal roles in human cancer development and progression, such as tumor metastasis. Here, we identified the miRNAs that regulate hepatocellular carcinoma (HCC) cell migration by a high-throughput screening method using the classical wound-healing assay with time-lapse video microscopy and validation with a transwell migration assay. Eleven miRNAs (miR-134, -146b-3p, -188-3p, -525-3p, -661, -767-5p, -891a, -891b, -1244, -1247 and miR-1471) were found to promote or inhibit HCC cell migration. Further investigation revealed that miR-134 suppressed the invasion and metastasis of HCC cells in vitro and in vivo, and integrin beta 1 (ITGB1) was a direct and functional target gene of miR-134. Moreover, miR-134 inhibited the phosphorylation of focal adhesion kinase (FAK) and the activation of RhoA downstream of the ITGB1 pathway, thereby decreasing stress fiber formation and cell adhesion in HCC cells. In conclusion, we demonstrated that miR-134 is a novel metastasis suppressor in HCC and could be a potential therapeutic target for the treatment of HCC.
Insights
MicroRNAs regulate hepatocellular carcinoma (HCC) cell migration. MiR-134 acts as a metastasis suppressor by targeting integrin beta 1, offering a potential therapeutic target for HCC treatment.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- MicroRNAs (miRNAs) are crucial non-coding RNAs involved in cancer development, including tumor metastasis.
- Hepatocellular carcinoma (HCC) cell migration is a key factor in its progression and metastasis.
Purpose of the Study:
- To identify specific miRNAs regulating hepatocellular carcinoma (HCC) cell migration.
- To investigate the role of miR-134 in HCC invasion and metastasis and its molecular targets.
Main Methods:
- High-throughput screening using wound-healing and transwell migration assays to identify regulatory miRNAs.
- In vitro and in vivo experiments to assess miR-134's function in HCC metastasis.
- Luciferase reporter assays and Western blotting to validate ITGB1 as a direct target of miR-134 and assess downstream signaling pathways (FAK, RhoA).
Main Results:
- Eleven miRNAs were identified as regulators of HCC cell migration.
- miR-134 significantly suppressed HCC cell invasion and metastasis both in vitro and in vivo.
- Integrin beta 1 (ITGB1) was confirmed as a direct target of miR-134, with miR-134 inhibiting downstream FAK and RhoA signaling, reducing cell adhesion.
Conclusions:
- miR-134 functions as a novel tumor suppressor in HCC by inhibiting cell migration and metastasis.
- miR-134 represents a potential therapeutic target for managing HCC metastasis.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs